Mitochondrial dysfunction in Parkinson's disease

Winklhofer, Konstanze F., Haass, Christian·2010·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Cited by (690)

Items 201–300 of 690

  1. Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats
    Nidhika Sharma, Sumit Jamwal, Puneet Kumar · 2016 · Pathophysiology
  2. The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration
    YuHong Fu, George Paxinos, CHARLES R. R. WATSON, Glenda Margaret Halliday · 2016 · Journal of Chemical Neuroanatomy
  3. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin
    Hui Yang, Xiaoping Zhou, Xiaoyu Liu, Ling Yang, Qiang Chen, Dongliang Zhao, Ji Zuo, Wen Liu · 2011 · Biochemical and Biophysical Research Communications
  4. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration
    Joseph McInnes · 2013 · Translational Neurodegeneration
  5. Activation mechanisms of the E3 ubiquitin ligase parkin
    Nikhil Panicker, Valina Lynn Dawson, Ted M. Dawson · 2017 · Biochemical Journal
  6. Effectiveness of γ-oryzanol in reducing neuromotor deficits, dopamine depletion and oxidative stress in a Drosophila melanogaster model of Parkinson's disease induced by rotenone
    Stífani Machado Araújo, Mariane Trindade de Paula, Márcia Rósula Poetini, Luana Barreto Meichtry, Vandreza Cardoso Bortolotto, Micheli Stéfani Zarzecki, Cristiano Ricardo Jessé, Marina Prigol · 2015 · NeuroToxicology
  7. Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation
    Ju‐Xian Song, Pang‐Chui Shaw, Stephen Cho Wing Sze, Yao Tong, Xin‐Sheng Yao, Tzi‐Bun Ng, Yanbo Zhang · 2010 · Neurochemistry International
  8. Neurochemical correlation between major depressive disorder and neurodegenerative diseases
    Gislaine Z. Réus, Stephanie E. Titus, Helena M. Abelaira, Sharon M. Freitas, Talita Tuon, João Quevedo, Josiane Budni · 2016 · Life Sciences
  9. Copy number variability in Parkinson’s disease: assembling the puzzle through a systems biology approach
    Valentina La Cognata, Giovanna Morello, Velia D’Agata, Sebastiano Cavallaro · 2016 · Human Genetics
  10. Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders
    Pravir Kumar, Kaveri Pradhan, Karunya Ramani, Rashmi K. Ambasta, Henry W. Querfurth · 2011 · Journal of Neurochemistry
  11. Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders
    Micha M.M. Wilhelmus, Philip G. Nijland, Benjamin Drukarch, Helga E. de Vries, Jack van Horssen · 2012 · Free Radical Biology and Medicine
  12. Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
    Eduardo Luiz Gasnhar Moreira, Daniel Rial, Aderbal S. Aguiar, Cláudia Pinto Figueiredo, Jarbas Mota Siqueira, Silvia DalBó, Heros Horst, Jade de Oliveira, Gianni Mancini, Tiago Souza dos Santos et al. · 2010 · Journal of Neural Transmission
  13. Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression
    Yuehua Wang, Haitao Yu, Xiaoping Pu, Guanhua Du · 2013 · Molecules
  14. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson’s Disease
    Valentín Cóppola-Segovia, Clarissa F. Cavarsan, Flavia Gulak Maia, Anete Curte Ferraz, Lia S. Nakao, Marcelo MS Lima, Sílvio Marques Zanata · 2016 · Molecular Neurobiology
  15. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson’s Disease
    Karamkolly R. Rekha, Ramu Inmozhi Sivakamasundari · 2018 · Neurochemical Research
  16. Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
    Sandrine C. Foti, Iain Parry Hargreaves, Stephanie Carrington, Aoife P. Kiely, Henry Houlden, Janice L. Holton · 2019 · Scientific Reports
  17. Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity
    Prashant Tarale, Tapan Chakrabarti, Saravanadevi Sivanesan, Pravin Krishnarao Naoghare, Amit Bafana, Kannan Krishnamurthi · 2016 · BioMed Research International
  18. Altered Slc25 family gene expression as markers of mitochondrial dysfunction in brain regions under experimental mixed anxiety/depression-like disorder
    Vladimir N. Babenko, Дмитрий Александрович Смагин, Anna G. Galyamina, Irina L. Kovalenko, N. N. Kudryavtseva · 2018 · BMC Neuroscience
  19. The interplay between mitochondria and autophagy and its role in the aging process
    Alfonso Schiavi, Natascia Ventura · 2014 · Experimental Gerontology
  20. Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
    Edward D. Plowey, Charleen T. Chu · 2010 · Neurobiology of Disease
  21. Parkin Impairs Antiviral Immunity by Suppressing the Mitochondrial Reactive Oxygen Species-Nlrp3 Axis and Antiviral Inflammation
    Jian Li, Chunmei Ma, Fei Long, Dongxue Yang, Xue Liu, Yingchao Hu, Chunyan Wu, Bingwei Wang, Min Wang, Yunzi Chen et al. · 2019 · iScience
  22. Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model
    Mareike E. Fett, Anna Pilsl, Dominik Paquet, Frauke van Bebber, Christian Haass, Jörg Tatzelt, Bettina Schmid, Konstanze F. Winklhofer · 2010 · PLoS ONE
  23. Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway
    Lingling Zhang, Wenjun Ding, Huixing Sun, Qiong Zhou, Jingqun Huang, Xuefen Li, Yonghong Xie, Jianzong Chen · 2012 · Food and Chemical Toxicology
  24. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Tsu‐Kung Lin, Cha-Wei Liou, Shang‐Der Chen, Yao‐Chung Chuang, Mao‐Meng Tiao, Pei‐Wen Wang, Jin‐Bor Chen, Jiin‐Haur Chuang · 2009 · PubMed
  25. Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
    Perry G. Ridge, John S. K. Kauwe · 2018 · Current Genetic Medicine Reports
  26. IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson’s disease
    Rupinder Kaur Sodhi, Yashika Bansal, Raghunath Singh, Priyanka Saroj, Ranjana Bhandari, Baldeep Kumar, Anurag Kuhad · 2021 · NeuroToxicology
  27. Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
    Hironori Yokoyama, Hiroto Uchida, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki · 2010 · Neurological Sciences
  28. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
    Galba Jean Beppe, Alain Bertrand Dongmo, Harquin Simplice Foyet, Nolé Tsabang, Zenovia Olteanu, Oana Cioancă, Monica Hăncianu, Théophile Dimo, Lucian Hriţcu · 2014 · BMC Complementary and Alternative Medicine
  29. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
    Sugumar Mani, Murugan Sevanan, Alagudurai Krishnamoorthy, Sathiya Sekar · 2021 · Neurological Sciences
  30. POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview
    Daniele Orsucci, Elena Caldarazzo Ienco, Michelangelo Mancuso, Gabriele Siciliano · 2011 · Journal of Molecular Neuroscience
  31. Presence of Tissue Transglutaminase in Granular Endoplasmic Reticulum is Characteristic of Melanized Neurons in Parkinson's Disease Brain
    Micha M.M. Wilhelmus, Robin Verhaar, Gerda Andringa, John G. J. M. Bol, Patrick P Cras, Ling Shan, Jeroen J.M. Hoozemans, Benjamin Drukarch · 2010 · Brain Pathology
  32. Procyanidin B2 Protects Neurons from Oxidative, Nitrosative, and Excitotoxic Stress
    Taylor Sutcliffe, Aimee N. Winter, Noelle Punessen, Daniel A. Linseman · 2017 · Antioxidants
  33. Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
    Claudia Funke, Susanne A. Schneider, Daniela Berg, Douglas Bruce Kell · 2012 · Neurochemistry International
  34. Auditory Dysfunction in Parkinson's Disease
    Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2020 · Movement Disorders
  35. Oxidative stress-induced proteome alterations target different cellular pathways in human myoblasts
    Martín A. Baraibar, Janek Hyzewicz, Adelina Rogowska-Wrzesińska, Romain Ladouce, Peter Roepstorff, Vincent Mouly, Bertrand Friguet · 2011 · Free Radical Biology and Medicine
  36. Pinocembrin Protects SH-SY5Y Cells Against MPP+-Induced Neurotoxicity Through the Mitochondrial Apoptotic Pathway
    Yumin Wang, Jun-Hong Gao, Yingchun Miao, Qifu Cui, Weili Zhao, Junyi Zhang, Hongquan Wang · 2014 · Journal of Molecular Neuroscience
  37. The primary role of glutathione against nuclear DNA damage of striatum induced by permethrin in rats
    Maria Letizia Falcioni, Cinzia Nasuti, Christian Bergamini, Romana Fato, Giorgio Lenaz, Rosita Gabbianelli · 2010 · Neuroscience
  38. Effects of chronic low dose rotenone treatment on human microglial cells
    Shamim B. Shaikh, Louise F. B. Nicholson · 2009 · Molecular Neurodegeneration
  39. Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
    Gideon L. Hughes, Michael A. Lones, Matthew Bedder, Peter David Currie, Stephen L. Smith, Mary Elizabeth Pownall · 2020 · Disease Models & Mechanisms
  40. The <i>parkin</i> Mutant Phenotype in the Fly Is Largely Rescued by Metal-Responsive Transcription Factor (MTF-1)
    Saini, Nidhi, Georgiev, Oleg, Schaffner, Walter · 2011 · Molecular and Cellular Biology
  41. Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
    Huifang Liu, Philip Wing‐Lok Ho, Gideon Chi-Ting Leung, Colin Siu-Chi Lam, Shirley Yin-Yu Pang, Lingfei Li, Michelle Hiu-Wai Kung, David Boyer Ramsden, Shu‐Leong Ho · 2017 · Scientific Reports
  42. Testosterone Upregulates the Expression of Mitochondrial ND1 and ND4 and Alleviates the Oxidative Damage to the Nigrostriatal Dopaminergic System in Orchiectomized Rats
    Wensheng Yan, Yunxiao Kang, Xiaoming Ji, Shuangcheng Li, Yingkun Li, Guoliang Zhang, Huixian Cui, Geming Shi · 2017 · Oxidative Medicine and Cellular Longevity
  43. Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
    PhilipV Peplow, Bridget Martinez · 2018 · Neural Regeneration Research
  44. Lipid Unsaturation Properties Govern the Sensitivity of Membranes to Photoinduced Oxidative Stress
    Aurélien Bour, Sergei G. Kruglik, Morgan Chabanon, Padmini Rangamani, Nicolas Puff, Stéphanie Bonneau · 2019 · Biophysical Journal
  45. Extremely Low Frequency Magnetic Field (ELF-MF) Exposure Sensitizes SH-SY5Y Cells to the Pro-Parkinson’s Disease Toxin MPP+
    Barbara Benassi, Giuseppe Filomeni, Costanza Montagna, Caterina Merla, Vanni Lopresto, Rosanna Pinto, Carmela Marino, Claudia Consales · 2015 · Molecular Neurobiology
  46. Bipolar and fixable probe targeting mitochondria to trace local depolarization via two-photon fluorescence lifetime imaging
    Benlei Wang, Xinfu Zhang, Chao Wang, Lingcheng Chen, Yi Xiao, Yi Pang · 2015 · The Analyst
  47. Mitophagy and neurodegeneration
    Kim Wager, Claire Russell · 2013 · Autophagy
  48. Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency
    Kambiz N. Alavian, Steven I. Dworetzky, Laura Bonanni, Ping Zhang, Silvio Sacchetti, Maria Addolorata Mariggiò, MARCO C. ONOFRJ, Astrid Thomas, Hongmei Li, Jamie E. Mangold et al. · 2012 · Brain Research
  49. High-depth fluorescence imaging using a two-photon FRET system for mitochondrial pH in live cells and tissues
    Min Jung Chang, Kyutae Kim, Kyun Seob Park, Ji Su Kang, Chang Su Lim, Hwan Myung Kim, Chulhun Kang, Min Hee Lee · 2018 · Chemical Communications
  50. A new insight on elderberry anthocyanins bioactivity: Modulation of mitochondrial redox chain functionality and cell redox state
    Dina Neves, Patrı́cia Valentão, João Bernardo, M.C. Oliveira, Jorge M.G. Ferreira, David M. Pereira, Paula B. Andrade, Romeu António Videira · 2019 · Journal of Functional Foods
  51. Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention
    Yingying Wang, Qianqian Wang, Xiao Han, Yingchao Ma, Zhenkun Zhang, Liang Zhao, Fangxia Guan, Shanshan Ma · 2021 · Food & Function
  52. Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction
    Jie Li, Wenzhe Ma, Pingyuan Wang, Paula J. Hurley, Fred Bunz, Paul M. Hwang · 2014 · Free Radical Biology and Medicine
  53. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates
    Hideaki Matsui, Roberto Gavinio, Takeshi Asano, Norihito Uemura, Hidefumi Ito, Yoshihito Taniguchi, Yoshito Kobayashi, Takakuni Maki, Jie Shen, Shunichi Takeda et al. · 2013 · Human Molecular Genetics
  54. Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria
    Rizwan Nisar, Peter S. Hanson, L. He, Robert W. Taylor, Peter G. Blain, Christopher M. Morris · 2015 · Archives of Toxicology
  55. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: Relevance to oxidative stress and neuroinflammation in Parkinson's disease
    Anumantha G. Kanthasamy, Huajun Jin, Suneet Mehrotra, Rajakishore Mishra, Arthi Kanthasamy, Ajay Rana · 2009 · NeuroToxicology
  56. Probucol Affords Neuroprotection in a 6-OHDA Mouse Model of Parkinson’s Disease
    Renata Pietsch Ribeiro, Eduardo Luiz Gasnhar Moreira, Danúbia Bonfanti Santos, Dirleise Colle, Alessandra Antunes dos Santos, Kaite Cristiane Peres, Cláudia Pinto Figueiredo, Marcelo Farina · 2013 · Neurochemical Research
  57. MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling
    Cui Ma, Chen Zhang, Mingfei Ma, Lixin Zhang, Linlin Zhang, Fengying Zhang, Yingli Chen, Fangyuan Cao, Minghui Li, Guangtian Wang et al. · 2017 · Journal of Molecular Medicine
  58. Rifampicin and Parkinson’s disease
    Wei Bi, Lihong Zhu, Xiuna Jing, Yanran Liang, Enxiang Tao · 2012 · Neurological Sciences
  59. Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment
    Xiaoyi Chen, Yunjiang Feng, Ronald J. Quinn, Dean L. Pountney, Des Raymond Richardson, George D. Mellick, Linlin Ma · 2023 · Pharmacological Reviews
  60. Regulation and protection of mitochondrial physiology by sirtuins
    Cláudia V. Pereira, Magdalena Lebiedzińska, Mariusz Roman Wieckowski, Paulo Jorge Oliveira · 2011 · Mitochondrion
  61. Signalling mechanisms underlying development and maintenance of dopamine neurons
    Jaan‐Olle Andressoo, Märt Saarma · 2008 · Current Opinion in Neurobiology
  62. Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson’s disease
    Christopher A Bates, Wei Zheng · 2014 · Fluids and Barriers of the CNS
  63. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
    Nadhir Litim, Marc Morissette, Thérèse Di Paolo · 2015 · Neuroscience & Biobehavioral Reviews
  64. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells
    Anja Hafner Pišlar, Nace Zidar, D. Kikelj, Janko Kos · 2013 · Neuropharmacology
  65. Mesenchymal stromal cells donate mitochondria to articular chondrocytes exposed to mitochondrial, environmental, and mechanical stress
    Megan J. Fahey, Maureen Bennett, Matthew Thomas, Kaylee L. Montney, Irene Vivancos Koopman, Brenna R. Pugliese, Lindsay Browning, Lawrence J. Bonassar, Michelle L. Delco · 2022 · Scientific Reports
  66. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and l-dopa toxicity
    Amany A. Abdin, Naglaa Sarhan · 2011 · Neuroscience Research
  67. Quantitative variations of the mitochondrial proteome and phosphoproteome during fermentative and respiratory growth in Saccharomyces cerevisiae
    Margaux Renvoisé, Ludovic Bonhomme, Marlène Davanture, Benoı̂t Valot, Michel Zivy, Claire Lemaire · 2014 · Journal of Proteomics
  68. PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts
    Giuseppina Amodio, Ornella Moltedo, D Fasano, Lucrezia Zerillo, Marco Oliveti, Paola Di Pietro, Raffaella Faraonio, Paolo Barone, Maria Teresa Pellecchia, Anna De Rosa et al. · 2019 · Frontiers in Neuroscience
  69. Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice
    Sha-Ron Pierre, Marijke A.M. Lemmens, Maria E. Figueiredo‐Pereira · 2009 · Journal of Neuroinflammation
  70. Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    Viviana Brembati, Gaia Faustini, Francesca Longhena, Arianna Bellucci · 2023 · Frontiers in Molecular Neuroscience
  71. Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the α-synuclein overexpression
    Mu‐Hui Fu, Chih‐Wei Wu, Yu‐Chi Lee, Chun‐Ying Hung, I‐Chun Chen, Kay L. H. Wu · 2018 · Biomedical Journal
  72. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
    Saeideh Momtaz, Zahra Memariani, Fardous F. El‐Senduny, Nima Sanadgol, Fereshteh Golab, Majid Katebi, Amir Hossein Abdolghaffari, Mohammad Hosein Farzaei, Mohammad Reza Abdollahi · 2020 · Frontiers in Physiology
  73. Mitochondrial DNA sequence variation and neurodegeneration
    Michelangelo Mancuso, Massimiliano Filosto, Daniele Orsucci, Gabriele Siciliano · 2008 · Human Genomics
  74. Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
    Swarup Mitra, Avijit Banik, Sumit Saurabh, Malabika Maulik, Shailesh Khatri · 2022 · Journal of Neuroscience
  75. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress
    Michael Klinkenberg, N Thurow, Suzana Gispert, Filomena Ricciardi, Florian Eich, Jochen H.M. Prehn, Georg W. J. Auburger, Donat Kögel · 2010 · Neuroscience
  76. Betaine Protects Against Rotenone-Induced Neurotoxicity in PC12 Cells
    A‐Rang Im, Young‐Hwa Kim, Md. Romij Uddin, Sungwook Chae, Hye Won Lee, Yun Hee Kim, Yeong Shik Kim, Mi Young Lee · 2013 · Cellular and Molecular Neurobiology
  77. Metabolic Profile Analysis of Zebrafish Embryos
    Yann Gibert, Sean L. McGee, Alister C. Ward · 2013 · Journal of Visualized Experiments
  78. Iron in Neurodegenerative Disorders of Protein Misfolding: A Case of Prion Disorders and Parkinson's Disease
    Neena Singh, Swati Haldar, Ajai K. Tripathi, Matthew K. McElwee, Katharine Horback, Amber Beserra · 2014 · Antioxidants and Redox Signaling
  79. Mitochondrial injury and cognitive function in HIV infection and methamphetamine use
    Susanna R. Var, Tyler R. C. Day, Andrej Vitomirov, Davey Mitchell Smith, Virawudh Soontornniyomkij, David J. Moore, Cristian L. Achim, Sanjay R. Mehta, Josué Pérez‐Santiago · 2016 · AIDS
  80. Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells
    Rita Perfeito, Márcio Ribeiro, Ana Cristina Rego · 2016 · Archives of Toxicology
  81. How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications
    George Anderson, Michael H. J. Maes · 2017 · CNS & Neurological Disorders - Drug Targets
  82. The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats
    Christine N. Habib, Mohamed R. Mohamed, Mariane G. Tadros, Mai Fathy Tolba, Esther T. Menze, Somia I. Masoud · 2021 · European Journal of Pharmacology
  83. TRP channels: Role in neurodegenerative diseases and therapeutic targets
    Mashoque Ahmad Rather, Andleeb Khan, Lianchun Wang, Sadaf Jahan, Muneeb U. Rehman, Hafiz Antar Makeen, Syam Mohan · 2023 · Heliyon
  84. Novel role of transglutaminase 1 in corpora amylacea formation?
    Micha M.M. Wilhelmus, Robin Verhaar, John G. J. M. Bol, Anne‐Marie van Dam, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemüller, Benjamin Drukarch · 2009 · Neurobiology of Aging
  85. Arsenic-induced mitochondrial oxidative damage is mediated by decreased PGC-1α expression and its downstream targets in rat brain
    Chandra Prakāsh, Vijay Jyoti Kumar · 2016 · Chemico-Biological Interactions
  86. Epigenetic Mechanisms of Traumatic Brain Injuries
    Nagalakshmi Balasubramanian, Sneha Sagarkar, Amul J. Sakharkar · 2018 · Progress in molecular biology and translational science
  87. Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1
    Swetha Pavani Rao, Neelam Sharma, Shasi V. Kalivendi · 2020 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  88. Effects of Fluoride Long-Term Exposure over the Cerebellum: Global Proteomic Profile, Oxidative Biochemistry, Cell Density, and Motor Behavior Evaluation
    Géssica de Oliveira Lopes, Maria Karolina Martins Ferreira, Lodinikki Lemoy Davis, Leonardo Oliveira Bittencourt, Walessa Alana Bragança Aragão, Aline Salgado Dionizio, Marília Afonso Rabelo Buzalaf, Maria Elena Crespo Lopez, Cristiane do Socorro Ferraz Maia, Rafael Rodrigues Lima · 2020 · International Journal of Molecular Sciences
  89. Metabolomics in degenerative brain diseases
    Melissa Quintero Escobar, João Guilherme de Moraes Pontes, Ljubica Tasić · 2021 · Brain Research
  90. Increased risk of Parkinson's disease in cataract patients: A population-based cohort study
    Shih‐Wei Lai, Cheng‐Li Lin, Kuan‐Fu Liao, Kao-Chi Chang-Ou · 2014 · Parkinsonism & Related Disorders
  91. The rich electrochemistry and redox reactions of the copper sites in the cellular prion protein
    Feimeng Zhou, Glenn L. Millhauser · 2012 · Coordination Chemistry Reviews
  92. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson’s disease
    Hyun Jin Kim, Sung Hwan Kim, Hanvit Cha, Sang Ryong Kim, Jin Hyup Lee, Jeen‐Woo Park · 2016 · Free Radical Research
  93. Long Non-coding RNAs in Parkinson’s Disease
    Chengqi Xin, Jing Liu · 2021 · Neurochemical Research
  94. Dopaminergic Axons: Key Recitalists in Parkinson’s Disease
    Abhishek Kumar Mishra, Anubhuti Dixit · 2021 · Neurochemical Research
  95. Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
    Zheng Chen, Thangiah Geetha, Jeganathan Ramesh Babu · 2014 · Neurodegenerative Diseases
  96. Mask loss-of-function rescues mitochondrial impairment and muscle degeneration of Drosophila pink1 and parkin mutants
    Mingwei Zhu, Xia Li, Xiaolin Tian, Chunlai Wu · 2015 · Human Molecular Genetics
  97. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease
    Nadhir Litim, Mélanie Bourque, Sara Al-Sweidi, Marc Morissette, Thérèse Di Paolo · 2015 · Neuropharmacology
  98. Organic Fluorescent Probes for Monitoring Micro-Environments in Living Cells and Tissues
    Rui Yang, Tao Zhu, Jingyang Xu, Yuang Zhao, Yawei Kuang, Mengni Sun, Yuqi Chen, Wei He, Zixing Wang, Tingwang Jiang et al. · 2023 · Molecules
  99. L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL
    Haigang Ren, Kai Fu, Chenchen Mu, Xuechu Zhen, Guanghui Wang · 2012 · Molecular Neurodegeneration
  100. Alterations in mitochondrial membrane potential in peripheral blood mononuclear cells in Parkinson’s Disease: Potential for a novel biomarker
    Rizwana Qadri, Manju Namdeo, Madhuri Behari, Vinay Goyal, Subhadra Sharma, Asok Kumar Mukhopadhyay · 2018 · Restorative Neurology and Neuroscience